SCHEMBL454712

SCHEMBL454712

O=CCC1CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23199282 0.97 GABRA5 (0.40)
SCHEMBL21686127 0.85
SCHEMBL25455590 0.85
Propionic Acid SCHEMBL27306342 0.84 GABRA5 (0.48)
Tert-Butyl Formate SCHEMBL27595539 0.81 TDP1 (0.45)
SCHEMBL76463 0.80
SCHEMBL30816862 0.78 ALDH1A1 (0.32)
SCHEMBL7138787 0.78 GBA1 (0.38)
SCHEMBL6379288 0.77
SCHEMBL2409711 0.75 GABRA5 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104710408-A Chiral cis-imidazolines HOFFMANN LA ROCHE 2015-06-17 CN claimed
CN-101821251-A Chiral cis-imidazolines HOFFMANN LA ROCHE 2010-09-01 CN claimed
CN-101316823-A 2,4, 5-triphenylimidazoline derivatives as inhibitors of the interaction between p53 and MDM2 proteins for use as anticancer agents HOFFMANN LA ROCHE (CH) 2008-12-03 CN claimed
CN-1800163-A Dissymmetrical diazo compounds comprising 2-pyridinium group and a cationic or non-cationic linker, compositions comprising them, method for coloring, and device OREAL (FR) 2006-07-12 CN claimed
EP-4606803-A1 KRAS G12D DEGRADATION AGENT, AND PREPARATION METHOD AND USE THEREFOR Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. (CN) 2025-08-27 EP disclosed
WO-2025049820-A1 STAT6 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2025-03-06 WO disclosed
EP-4499628-A1 2,4-DIOXOTETRAHYDROPYRIMIDINYL DERIVATIVES AS DEGRONS IN PROTACS GlaxoSmithKline Intellectual Property Development Limited (GB) 2025-02-05 EP disclosed
CN-111777593-B Novel compounds as inhibitors of rearrangement kinase during transfection 南京天印健华医药科技有限公司 2024-07-23 CN disclosed
WO-2024130161-A2 NOVEL CAMPTOTHECIN DERIVATIVES AND CONJUGATES THEREOF BIONECURE THERAPEUTICS INC (US) 2024-06-20 WO disclosed
WO-2024121290-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS AND USES THEREOF GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED (GB) 2024-06-13 WO disclosed
CN-117964623-A Targeted protein degradation compound and preparation method and application thereof 上海领泰生物医药科技有限公司 2024-05-03 CN disclosed
WO-2024083258-A1 KRAS G12C DEGRADATION AGENT, AND PREPARATION METHOD AND USE THEREFOR 上海领泰生物医药科技有限公司 2024-04-25 WO disclosed
CN-1034015-C Process to prepare cycloamine compounds EISAI CO LTD (JP) 1997-02-12 CN disclosed
CN-1024547-C Preparation method of cyclic amine compound EISAI CO LTD (JP) 1994-05-18 CN disclosed
CN-1073939-A A kind of preparation method of cyclic amine compound EISAI CO LTD (JP) 1993-07-07 CN disclosed
CN-1071417-A The preparation method of cyclic amine compound EISAI CO LTD (JP) 1993-04-28 CN disclosed
EP-0418933-A1 Derivatives of alcadienes, their preparations and medicinal compositions containing them and intermediates RHONE-POULENC SANTE (FR) 1991-03-27 EP disclosed
EP-0333071-A2 Polypeptides, methods for their preparation, pharmaceutical compositions comprising them and use Eisai Co., Ltd. (JP) 1989-09-20 EP disclosed
EP-0310484-A1 Derivatives of alkadienes, their preparations, medicinal compositions containing them, and intermediates RHONE-POULENC SANTE (FR) 1989-04-05 EP disclosed
CN-1030752-A Preparation method of cyclic amine compound EISAI CO LTD (JP) 1989-02-01 CN disclosed